vs
STANDARD BIOTOOLS INC.（LAB）与Orion Properties Inc.（ONL）财务数据对比。点击上方公司名可切换其他公司
Orion Properties Inc.的季度营收约是STANDARD BIOTOOLS INC.的1.8倍（$35.2M vs $19.6M），Orion Properties Inc.净利率更高（-101.7% vs -177.4%，领先75.7%），Orion Properties Inc.同比增速更快（-8.2% vs -11.5%），过去两年STANDARD BIOTOOLS INC.的营收复合增速更高（-12.2% vs -13.6%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
LAB vs ONL — 直观对比
营收规模更大
ONL
是对方的1.8倍
$19.6M
营收增速更快
ONL
高出3.3%
-11.5%
净利率更高
ONL
高出75.7%
-177.4%
两年增速更快
LAB
近两年复合增速
-13.6%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $35.2M |
| 净利润 | $-34.7M | $-35.8M |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | -101.5% |
| 净利率 | -177.4% | -101.7% |
| 营收同比 | -11.5% | -8.2% |
| 净利润同比 | -28.8% | -9.3% |
| 每股收益（稀释后） | $-0.09 | $-0.63 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LABONL
| Q4 25 | — | $35.2M | ||
| Q3 25 | $19.6M | $37.1M | ||
| Q2 25 | $21.8M | $37.3M | ||
| Q1 25 | $40.8M | $38.0M | ||
| Q4 24 | — | $38.4M | ||
| Q3 24 | $22.1M | $39.2M | ||
| Q2 24 | $22.5M | $40.1M | ||
| Q1 24 | $45.5M | $47.2M |
净利润LABONL
| Q4 25 | — | $-35.8M | ||
| Q3 25 | $-34.7M | $-69.0M | ||
| Q2 25 | $-33.5M | $-25.1M | ||
| Q1 25 | $-26.0M | $-9.4M | ||
| Q4 24 | — | $-32.8M | ||
| Q3 24 | $-26.9M | $-10.2M | ||
| Q2 24 | $-45.7M | $-33.8M | ||
| Q1 24 | $-32.2M | $-26.2M |
毛利率LABONL
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — |
营业利润率LABONL
| Q4 25 | — | -101.5% | ||
| Q3 25 | -168.5% | -185.8% | ||
| Q2 25 | -118.1% | -67.1% | ||
| Q1 25 | -80.8% | -24.4% | ||
| Q4 24 | — | -85.4% | ||
| Q3 24 | -120.9% | -25.9% | ||
| Q2 24 | -134.5% | -84.1% | ||
| Q1 24 | -132.2% | -55.4% |
净利率LABONL
| Q4 25 | — | -101.7% | ||
| Q3 25 | -177.4% | -186.0% | ||
| Q2 25 | -153.7% | -67.3% | ||
| Q1 25 | -63.8% | -24.6% | ||
| Q4 24 | — | -85.4% | ||
| Q3 24 | -122.0% | -26.1% | ||
| Q2 24 | -203.3% | -84.2% | ||
| Q1 24 | -70.6% | -55.6% |
每股收益（稀释后）LABONL
| Q4 25 | — | $-0.63 | ||
| Q3 25 | $-0.09 | $-1.23 | ||
| Q2 25 | $-0.09 | $-0.45 | ||
| Q1 25 | $-0.07 | $-0.17 | ||
| Q4 24 | — | $-0.59 | ||
| Q3 24 | $-0.07 | $-0.18 | ||
| Q2 24 | $-0.12 | $-0.60 | ||
| Q1 24 | $-0.27 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $22.4M |
| 总债务越低越好 | — | $465.0M |
| 股东权益账面价值 | $399.7M | $623.2M |
| 总资产 | $539.6M | $1.2B |
| 负债/权益比越低杠杆越低 | — | 0.75× |
8季度趋势，按日历期对齐
现金及短期投资LABONL
| Q4 25 | — | $22.4M | ||
| Q3 25 | $129.4M | $32.6M | ||
| Q2 25 | $158.6M | $17.4M | ||
| Q1 25 | $150.9M | $9.4M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | $210.6M | $16.6M | ||
| Q2 24 | $269.8M | $24.2M | ||
| Q1 24 | $287.1M | $23.6M |
总债务LABONL
| Q4 25 | — | $465.0M | ||
| Q3 25 | — | $483.0M | ||
| Q2 25 | — | $483.0M | ||
| Q1 25 | — | $505.0M | ||
| Q4 24 | — | $492.0M | ||
| Q3 24 | $55.2M | $485.0M | ||
| Q2 24 | $55.1M | $462.0M | ||
| Q1 24 | $55.0M | $471.0M |
股东权益LABONL
| Q4 25 | — | $623.2M | ||
| Q3 25 | $399.7M | $658.8M | ||
| Q2 25 | $424.5M | $728.0M | ||
| Q1 25 | $454.6M | $753.5M | ||
| Q4 24 | — | $763.9M | ||
| Q3 24 | $489.3M | $800.9M | ||
| Q2 24 | $510.3M | $816.1M | ||
| Q1 24 | $577.3M | $854.6M |
总资产LABONL
| Q4 25 | — | $1.2B | ||
| Q3 25 | $539.6M | $1.2B | ||
| Q2 25 | $557.0M | $1.3B | ||
| Q1 25 | $579.6M | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | $681.5M | $1.4B | ||
| Q2 24 | $708.7M | $1.3B | ||
| Q1 24 | $777.7M | $1.4B |
负债/权益比LABONL
| Q4 25 | — | 0.75× | ||
| Q3 25 | — | 0.73× | ||
| Q2 25 | — | 0.66× | ||
| Q1 25 | — | 0.67× | ||
| Q4 24 | — | 0.64× | ||
| Q3 24 | 0.11× | 0.61× | ||
| Q2 24 | 0.11× | 0.57× | ||
| Q1 24 | 0.10× | 0.55× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $23.6M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | — |
| 自由现金流率自由现金流/营收 | -118.1% | — |
| 资本支出强度资本支出/营收 | 4.5% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-111.1M | — |
8季度趋势，按日历期对齐
经营现金流LABONL
| Q4 25 | — | $23.6M | ||
| Q3 25 | $-22.2M | $5.7M | ||
| Q2 25 | $-20.7M | $11.6M | ||
| Q1 25 | $-30.3M | $-2.2M | ||
| Q4 24 | — | $54.3M | ||
| Q3 24 | $-27.9M | $13.8M | ||
| Q2 24 | $-39.0M | $17.0M | ||
| Q1 24 | $-62.5M | $11.0M |
自由现金流LABONL
| Q4 25 | — | — | ||
| Q3 25 | $-23.1M | — | ||
| Q2 25 | $-22.6M | — | ||
| Q1 25 | $-35.3M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-30.1M | — | ||
| Q2 24 | $-41.0M | — | ||
| Q1 24 | $-63.3M | — |
自由现金流率LABONL
| Q4 25 | — | — | ||
| Q3 25 | -118.1% | — | ||
| Q2 25 | -103.6% | — | ||
| Q1 25 | -86.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -136.4% | — | ||
| Q2 24 | -182.2% | — | ||
| Q1 24 | -138.9% | — |
资本支出强度LABONL
| Q4 25 | — | — | ||
| Q3 25 | 4.5% | — | ||
| Q2 25 | 8.7% | — | ||
| Q1 25 | 12.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.2% | — | ||
| Q2 24 | 8.6% | — | ||
| Q1 24 | 1.7% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
ONL
暂无分部数据
